Oryzon Genomics SA (ORYZF)
3.098
0.00 (0.00%)
USD |
OTCM |
Oct 07, 16:00
Oryzon Genomics Net Income (Quarterly) : -0.1678M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.1678M |
| March 31, 2026 | -1.432M |
| December 31, 2025 | -1.568M |
| September 30, 2025 | 0.3936M |
| June 30, 2025 | 0.1734M |
| March 31, 2025 | -1.787M |
| December 31, 2024 | -1.487M |
| September 30, 2024 | -1.352M |
| June 30, 2024 | 0.1137M |
| March 31, 2024 | -1.244M |
| December 31, 2023 | -1.852M |
| September 30, 2023 | -1.156M |
| June 30, 2023 | 1.154M |
| March 31, 2023 | -1.748M |
| December 31, 2022 | -2.345M |
| September 30, 2022 | -0.6379M |
| June 30, 2022 | 0.3557M |
| Date | Value |
|---|---|
| March 31, 2022 | -1.832M |
| September 30, 2021 | -1.836M |
| June 30, 2021 | 0.9656M |
| March 31, 2021 | -2.191M |
| December 31, 2020 | -1.352M |
| September 30, 2020 | -1.068M |
| June 30, 2020 | -0.2187M |
| March 31, 2020 | -1.271M |
| December 31, 2019 | -1.049M |
| September 30, 2019 | -1.092M |
| June 30, 2019 | -0.6162M |
| March 31, 2019 | -1.371M |
| December 31, 2018 | -0.8607M |
| September 30, 2018 | -1.140M |
| June 30, 2018 | 1.884M |
| March 31, 2018 | -1.259M |
| March 31, 2016 | -0.7984M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Pharma Mar SA | -1.130M |
| Grifols SA | 212.78M |
| ACADIA Pharmaceuticals, Inc. | 31.50M |
| Alkermes Plc | 0.501M |
| Alnylam Pharmaceuticals, Inc. | 164.49M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 0.1678M |
| EPS Diluted (Quarterly) | -0.0022 |
| Enterprise Value | 230.01M |
| Earnings Yield | -1.15% |
| Normalized Earnings Yield | -1.149 |